Ken Griffin Molecular Templates, Inc. Transaction History

Citadel Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.81 - $3.43 $89,817 - $380,338	110,886 Added 762.68%	125,425 $114,000
Q1 2022 May 16, 2022	BUY	$2.27 - $4.13 $1,489 - $2,709	656 Added 4.73%	14,539 $50,000
Q1 2021 May 17, 2021	SELL	$9.33 - $14.05 $553,819 - $833,993	-59,359 Reduced 81.05%	13,883 $175,000
Q4 2020 Feb 16, 2021	BUY	$8.48 - $12.23 $102,565 - $147,921	12,095 Added 19.78%	73,242 $688,000
Q3 2020 Nov 16, 2020	BUY	$9.99 - $14.41 $184,485 - $266,109	18,467 Added 43.27%	61,147 $668,000
Q2 2020 Aug 14, 2020	BUY	$12.28 - $17.63 $360,946 - $518,198	29,393 Added 221.22%	42,680 $589,000
Q2 2019 Aug 14, 2019	BUY	$5.83 - $8.42 $15,449 - $22,313	2,650 Added 24.91%	13,287 $111,000
Q4 2018 Feb 14, 2019	BUY	$3.35 - $5.68 $35,633 - $60,418	10,637 New	10,637 $42,000
Q4 2017 Feb 09, 2018	SELL	$7.04 - $11.31 $81,987 - $131,716	-11,646 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$5.0 - $7.14 $58,230 - $83,152	11,646	11,646 $81,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $7.33M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.